1. The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs
   Giovanni Barillari, 2020, Frontiers in Oncology CrossRef
2. Regulatory Role of IL6 in Immune-Related Adverse Events during Checkpoint Inhibitor Treatment in Melanoma
   Krishna P. Singh et al, 2024, International Journal of Molecular Sciences CrossRef
3. In Silico Modeling of FDA-Approved Drugs for Discovery of Anticancer Agents: A Drug-Repurposing Approach
   Mengzhu Zheng et al, 2019, In Silico Drug Design CrossRef
4. Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression
   Gan-guan Wei et al, 2019, Pathology - Research and Practice CrossRef
5. Inhibitors of HIV protease in cancer therapy
   E. Pontiki et al, 2020, Cancer-Leading Proteases CrossRef
6. Advanced Computational Pipeline for FAK Inhibitor Discovery: Combining Multiple Docking Methods with MD and QSAR for Cancer Therapy
   Pinar Siyah, 2024, Computation CrossRef
7. Drug repurposing: a retrospective revolution in breast cancer medicine
   Dave Shivani et al, 2024, Discover Medicine CrossRef
8. Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy
   Ahizechukwu C. Eke et al, 2020, Antimicrobial Agents and Chemotherapy CrossRef
9. Drug rechanneling: A novel paradigm for cancer treatment
   Itishree Kaushik et al, 2021, Seminars in Cancer Biology CrossRef
10. In silico approaches for drug repurposing in oncology: a scoping review
    Bruno Raphael Ribeiro Cavalcante et al, 2024, Frontiers in Pharmacology CrossRef